Core Viewpoint - Health 160 (02656) experienced a significant decline of nearly 40%, retracting most of its gains for the year, with its market capitalization briefly falling below HKD 20 billion [1] Group 1: Company Overview - Health 160 is an experienced wholesale distributor of pharmaceutical and health products in China and a leading provider of integrated digital healthcare services [1] - The company offers a variety of pharmaceutical health products and comprehensive digital healthcare solutions [1] Group 2: Market Performance - As of the latest report, Health 160's stock price dropped by 32.1%, trading at HKD 61.65, with a trading volume of HKD 32.83 million [1] - The company went public on September 17, 2025, and is facing a significant unlock of restricted shares, with 267 million shares (79% of the circulating shares) set to be released on the same date [1]
健康160重挫近40% 回吐年内多数涨幅 总市值一度跌穿200亿港元